---
title: "Weekly Recap | RTX +0.7%, wins $6.3b SM-3 contract"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/301471160.md"
description: "RTX rose 0.7% this week to close at $185.97, trailing the S&P 500 by about 0.45 percentage points. The week swung within a 4.04% range, with an early dip followed by a rebound. The stock slid from Monday through Wednesday, touching an intraweek low of $179.95 on 7 October and $179.02 the next day, before recovering on Thursday and Friday. Friday’s close of $185.97 was just below the week’s high."
datetime: "2026-10-10T07:32:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/301471160.md)
  - [en](https://longbridge.com/en/news/301471160.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/301471160.md)
generator: "portal-rs"
---

# Weekly Recap | RTX +0.7%, wins $6.3b SM-3 contract

## The Week

RTX rose 0.7% this week to close at $185.97, trailing the S&P 500 by about 0.45 percentage points. The week swung within a 4.04% range, with an early dip followed by a rebound. The stock slid from Monday through Wednesday, touching an intraweek low of $179.95 on 7 October and $179.02 the next day, before recovering on Thursday and Friday. Friday’s close of $185.97 was just below the week’s high.

## Key Events

The biggest company-specific development came late Thursday, when RTX’s Raytheon unit was awarded a $6.3 billion multi-year contract for SM-3 IB interceptors. Earlier in the week, the stock had logged eight consecutive down days, putting it on track for its longest losing streak since November 2023. On Friday morning, Citi said aerospace and defence names look close to a major tactical bottom after the sell-off, and RTX outperformed competitors in a strong session. Over the weekend, Barclays initiated coverage with an overweight rating.

## Analyst Ratings

Twenty-four brokers cover RTX: 11 rate it buy, 6 rate it overweight and 7 rate it hold, with no underweight or sell ratings. The consensus recommendation is buy, with a consensus target of $230.13, about 23.7% above the current price of $185.97. Targets range from $200 to $250, a spread that is wide but not extreme. Among 85 names in the aerospace and defence industry, RTX ranks 5th by analyst rating.

## The Week Ahead

US macro data starts on Tuesday with the NFIB small-business optimism index and existing-home sales. CPI and core CPI land on Wednesday, which could shape rate expectations. On the company side, RTX reports fiscal third-quarter results before the open on 20 October, with estimates pointing to EPS of about $1.50 and revenue of roughly $24 billion.

## In Short

RTX finished the week higher but lagged the broader market. The analyst setup is supportive, with a buy consensus and a target more than 20% above spot, while sector sentiment shows signs of stabilising. The tension sits in valuation and money flows, as large-lot money was a modest net seller in the latest session. The next validation points are the upcoming quarterly report and the CPI print’s effect on risk appetite.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [RTX.US](https://longbridge.com/en/quote/RTX.US.md)
- [RTXG.US](https://longbridge.com/en/quote/RTXG.US.md)

## Related News & Research

- [Axxcess Wealth Management LLC Sells 43,341 Shares of RTX Corporation $RTX](https://longbridge.com/en/news/302666874.md)
- [Raytheon (RTX): Buy Rating Reaffirmed as Strong Q3 Results and Upgraded Outlook Support Unchanged $235 Price Target](https://longbridge.com/en/news/302436766.md)
- [RTX's Collins Aerospace launches Tower MicroELITE surveillance solution at San Bernardino International Airport | RTX Stock News](https://longbridge.com/en/news/302544497.md)
- [RTX raises 2026 adjusted EPS outlook to $7.65-$7.75](https://longbridge.com/en/news/302415817.md)
- [RTX's Collins Aerospace introduces ARINCDirect℠ OpenAPI to connect flight support data across operator systems | RTX Stock News](https://longbridge.com/en/news/302576930.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**